Expanding Spine Care And Integrated Tech Will Drive Future Opportunities
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
27 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$18.95
17.2% undervalued intrinsic discount15 Aug
US$15.70
1Y
159.5%7D
2.5%